May Measurement Month 2022: results from the global blood pressure screening campaign

datacite.rightshttp://purl.org/coar/access_right/c_abf2
dc.contributor.authorBeaney, Thomas
dc.contributor.authorKeziah Kerr, Gabriele
dc.contributor.authorKiru, Gaia
dc.contributor.authorMcArdle, Harsha
dc.contributor.authorSchlaich, Markus
dc.contributor.authorSchutte, Aletta E.
dc.contributor.authorStergiou, George S.
dc.contributor.authorJi-guang, Wang
dc.contributor.authorMarin, Marcos J.
dc.contributor.authorHenandez-Hernandez, Rafael
dc.contributor.authorF. Diaz, Alejandro Bimbo
dc.contributor.authorAlcocer, Luis
dc.contributor.authorLopez-Jaramillo, Patricio
dc.contributor.authorPoulter, Neil
dc.contributor.authorLopez-Lopez, José P.
dc.contributor.authorOtero, Odont Johanna
dc.contributor.authorZulma, Urbina
dc.contributor.authorSanchez-Vallejo, Gregorio
dc.contributor.authorNarváez, Claudia
dc.contributor.authorCamacho, Paul A.
dc.contributor.authorUrina-Triana, Miguel
dc.contributor.authorQuintero, Adalberto
dc.contributor.authorAroca, Gustavo
dc.contributor.authorCampos, Alfonso
dc.contributor.authorArcos, Edgar
dc.contributor.authorPérez-Mayorga, Maritza
dc.contributor.authorMosquera, Walter
dc.contributor.authorGarcía-Ortiz, Luis H.
dc.date.accessioned2024-12-16T14:55:19Z
dc.date.available2024-12-16T14:55:19Z
dc.date.issued2024
dc.description.abstractIntroduction Elevated blood pressure (BP) is the major contributor to mortality and disease burden worldwide. May Measurement Month (MMM) is a global BP screening campaign, which aims to raise awareness of BP measurement and provide evidence to inform and influence related health policy. Methods This cross-sectional survey included individuals aged≥18 years recruited through opportunistic sampling at sites in 60 countries during MMM 2022. Each participant had three sitting BP measurements and a questionnaire was completed including demographics, comorbidities and lifestyle factors. Hypertension was defined as a systolic BP≥140 mm Hg and/or a diastolic BP≥90 mm Hg (average of the second and third readings) or taking antihypertensive medication. Multiple imputation was used to estimate BP readings where any participant’s BP readings were missing. Linear mixed effects models were used to identify associations between participant characteristics and systolic or diastolic BP. Results Of the 715 518 participants surveyed (excluding 50 200 self-measured home BP screenees recruited via the ZOE Health Study app), 257 421 (36.0%) were identified as hypertensive, of whom 57.6% were aware and 49.3% were on antihypertensive medication. Of all participants with hypertension, 26.1% were controlled to <140/90 mm Hg and 12.0% to <130/80 mm Hg. Of those taking antihypertensive medication, 52.7% were taking only one drug class, 52.9% were controlled to <140/90 mm Hg and 24.4% to 130/80 mm Hg. In total, 190 314 (26.6% of total surveyed, 73.9% of hypertensives) participants screened were found to have untreated or inadequately treated hypertension. Only 27.6% of treated hypertensive participants were taking a statin. Substantial coexistence of diabetes, overweight and hypertension was apparent among participants.eng
dc.format.mimetypepdf
dc.identifier.citationBeaney T, Kerr GK, Kiru G, et al. May Measurement Month 2022: results from the global blood pressure screening campaign. BMJ Glob Health 2024;9:e016557. doi:10.1136/bmjgh-2024-016557eng
dc.identifier.doihttps:// doi. org/ 10. 1136/bmjgh- 2024- 016557
dc.identifier.issn20597908 (Electrónico)
dc.identifier.urihttps://hdl.handle.net/20.500.12442/16065
dc.identifier.urlhttps://gh.bmj.com/content/9/12/e016557
dc.language.isoeng
dc.publisherBMJspa
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United Stateseng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/
dc.sourceBMJ Glob Healtheng
dc.sourceVol. 9, No. 12 (2024)spa
dc.subject.keywordsBlood pressureeng
dc.subject.keywordsCOVID-19eng
dc.subject.keywordsBP detectioneng
dc.titleMay Measurement Month 2022: results from the global blood pressure screening campaigneng
dc.type.driverinfo:eu-repo/semantics/article
dc.type.spaArtículo científico
dcterms.referencesPoulter N, Prabhakaran D, Hypertension CM. Lancet 2015;386:801–12.eng
dcterms.referencesGBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1223–49.eng
dcterms.referencesZhou B, Danaei G, Stevens GA, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. The Lancet 2019;394:639–51.eng
dcterms.referencesGeldsetzer P, Manne-Goehler J, Marcus M-E, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. The Lancet 2019;394:652–62.eng
dcterms.referencesPoulter NR, Lackland DT. May Measurement Month: a global blood pressure screening campaign. The Lancet 2017;389:1678–80.eng
dcterms.referencesPoulter NR, Borghi C, Castillo RR, et al. May Measurement Month 2017: Results of 39 national blood pressure screening programmes. Eur Heart J Suppl 2019;21:D1–4.eng
dcterms.referencesBeaney T, Schutte AE, Tomaszewski M, et al. May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health 2018;6:e736–43.eng
dcterms.referencesBeaney T, Burrell LM, Castillo RR, et al. May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. Eur Heart J 2019;40:2006–17.eng
dcterms.referencesBeaney T, Schutte AE, Stergiou GS, et al. May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension. Hypertension 2020;76:333–41.eng
dcterms.referencesBeaney T, Wang W, Schlaich MP, et al. Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign. J Hypertens 2023;41:1446–55.eng
dcterms.referencesDale CE, Takhar R, Carragher R, et al. The impact of the COVID-19 pandemic on cardiovascular disease prevention and management. Nat Med 2023;29:219–25.eng
dcterms.referencesGotanda H, Liyanage-Don N, Moran AE, et al. Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations. Hypertension 2022;79:2733–42.eng
dcterms.referencesJeemon P, Séverin T, Amodeo C, et al. World Heart Federation Roadmap for Hypertension - A 2021 Update. Glob Heart 2021;16:63.eng
dcterms.referencesMancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens 2023;41:1874–2071.eng
dcterms.referencesUnger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 2020;75:1334–57.eng
dcterms.referencesWilliams B, Mancia G, Spiering W, et al. ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J 2018;39:3021–104.eng
dcterms.referencesR Core Team. R: a language and environment for statistical computing. 2023.eng
dcterms.referencesStataCorp. Stata statistical software: release 18. 2023.eng
dcterms.referencesUN Statistics Division. Standard country or area codes for statistical use (M49). 2023.eng
dcterms.referencesThe World Bank. World bank country and lending groups. 2023.eng
dcterms.referencesSurveillance Epidemiology and End Results (SEER) Program. Standard populations - single ages.eng
dcterms.referencesSeaman SR, Bartlett JW, White IR. Multiple imputation of missing covariates with non-linear effects and interactions: an evaluation of statistical methods. BMC Med Res Methodol 2012;12:46.eng
dcterms.referencesLin Q, Ye T, Ye P, et al. Hypertension in stroke survivors and associations with national premature stroke mortality: data for 2·5 million participants from multinational screening campaigns. Lancet Glob Health 2022;10:e1141–9.eng
dcterms.referencesJanssen C, Wang W, Schlaich M, et al. S-53- 4: HYPERTENSION AND ITS ASSOCIATIONS WITH MULTIMORBIDITY: AN ANALYSIS OF 4 MILLION PARTICIPANTS FROM MAY MEASUREMENT MONTH 2017–2019. J Hypertens (Los Angel) 2023;41:e117–8.eng
dcterms.referencesKerr GK, Schlaich M, Schutte AE, et al. PS-P04- 7: ALERTING REACTION OF BLOOD PRESSURE AND AGE: MAY MEASUREMENT MONTH 2019. J Hypertens (Los Angel) 2023;41:e247–8.eng
dcterms.referencesKerr GK, Schlaich M, Schutte AE, et al. PS-P04- 8: COMPARISON OF INDICES OF WITHIN-VISIT BLOOD PRESSURE VARIABILITY IN MAY MEASUREMENT MONTH 2019. J Hypertens (Los Angel) 2023;41:e248.eng
dcterms.referencesWorld Health Organisation. Post COVID-19 condition (long COVID). 2022.eng
dcterms.referencesMatsumoto C, Shibata S, Kishi T, et al. Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19. Hypertens Res 2023;46:601–19.eng
dcterms.referencesSedgwick P. Convenience sampling. BMJ 2013;347:f6304.eng
dcterms.referencesChen S, Sudharsanan N, Huang F, et al. Impact of community based screening for hypertension on blood pressure after two years: regression discontinuity analysis in a national cohort of older adults in China. BMJ 2019;366.eng
oaire.versioninfo:eu-repo/semantics/publishedVersion

Archivos

Bloque original
Mostrando 1 - 2 de 2
Cargando...
Miniatura
Nombre:
PDF.pdf
Tamaño:
1.8 MB
Formato:
Adobe Portable Document Format
Cargando...
Miniatura
Nombre:
PDF_supplement.pdf
Tamaño:
1.31 MB
Formato:
Adobe Portable Document Format
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
381 B
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones